vanoxerine has been researched along with alpha-synuclein in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alessandrí, MG; Fornai, F; Geppert, M; Jahn, R; Schlüter, OM; Südhof, TC; Takamori, S | 1 |
Chadchankar, H; Yavich, L | 1 |
Bellenchi, GC; Cacace, F; Calabresi, P; De Leonibus, E; De Risi, M; Ghiglieri, V; Giordano, N; Iemolo, A; Latagliata, EC; Mancini, M; Picconi, B; Puglisi-Allegra, S | 1 |
3 other study(ies) available for vanoxerine and alpha-synuclein
Article | Year |
---|---|
Role of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adrenergic Uptake Inhibitors; alpha-Synuclein; Animals; Antibodies; Blastomeres; Blotting, Southern; Corpus Striatum; Disease Models, Animal; DNA Primers; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Glutamic Acid; Hippocampus; Homovanillic Acid; Humans; Immunoblotting; Immunohistochemistry; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; MPTP Poisoning; Nerve Tissue Proteins; Neurons; Parkinsonian Disorders; Piperazines; Rats; Reserpine; Serotonin; Stem Cells; Subcellular Fractions; Substantia Nigra; Synucleins; Tyrosine 3-Monooxygenase | 2003 |
Sub-regional differences and mechanisms of the short-term plasticity of dopamine overflow in striatum in mice lacking alpha-synuclein.
Topics: alpha-Synuclein; Analysis of Variance; Animals; Biophysical Phenomena; Biophysics; Blood Proteins; Brain Mapping; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine Uptake Inhibitors; Electric Stimulation; Haloperidol; Male; Medial Forebrain Bundle; Mice; Mice, Inbred C57BL; Mice, Knockout; Neural Inhibition; Neuronal Plasticity; Piperazines; Time Factors | 2011 |
Motor learning and metaplasticity in striatal neurons: relevance for Parkinson's disease.
Topics: alpha-Synuclein; Animals; Benzazepines; Corpus Striatum; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Green Fluorescent Proteins; Learning; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; Motor Activity; Motor Skills; Neuronal Plasticity; Neurons; Piperazines; Reaction Time; Synapsins; Synaptophysin; Tyrosine 3-Monooxygenase | 2018 |